Clinical trial

[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate or Salivary Gland Cancer

NCT00588185

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate or Salivary Gland Cancer

Design: INTERVENTIONAL · Status: RECRUITING · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2003-02-01

PhaseNA

Conditions

Prostate Cancerverified · MONDO: prostate cancer

Interventions

[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-TestosteroneDRUG

Sponsors & collaborators

Memorial Sloan Kettering Cancer Centerlead sponsor

Mapped research locations

New YorkNew York, United States1 CommackNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00588185 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.